185 related articles for article (PubMed ID: 28281325)
1. BRAF mutations are associated with increased iron regulatory protein-2 expression in colorectal tumorigenesis.
Horniblow RD; Bedford M; Hollingworth R; Evans S; Sutton E; Lal N; Beggs A; Iqbal TH; Tselepis C
Cancer Sci; 2017 Jun; 108(6):1135-1143. PubMed ID: 28281325
[TBL] [Abstract][Full Text] [Related]
2. Excess capacity of the iron regulatory protein system.
Wang W; Di X; D'Agostino RB; Torti SV; Torti FM
J Biol Chem; 2007 Aug; 282(34):24650-9. PubMed ID: 17604281
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic mutation in RAS-RAF axis leads to increased expression of GREB1, resulting in tumor proliferation in colorectal cancer.
Kochi M; Hinoi T; Niitsu H; Miguchi M; Saito Y; Sada H; Sentani K; Sakamoto N; Oue N; Tashiro H; Sotomaru Y; Yasui W; Ohdan H
Cancer Sci; 2020 Oct; 111(10):3540-3549. PubMed ID: 32629543
[TBL] [Abstract][Full Text] [Related]
4. Changed iron regulation in scrapie-infected neuroblastoma cells.
Fernaeus S; Hälldin J; Bedecs K; Land T
Brain Res Mol Brain Res; 2005 Feb; 133(2):266-73. PubMed ID: 15710243
[TBL] [Abstract][Full Text] [Related]
5. IRP2 regulates breast tumor growth.
Wang W; Deng Z; Hatcher H; Miller LD; Di X; Tesfay L; Sui G; D'Agostino RB; Torti FM; Torti SV
Cancer Res; 2014 Jan; 74(2):497-507. PubMed ID: 24285726
[TBL] [Abstract][Full Text] [Related]
6. Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice.
Ghosh MC; Tong WH; Zhang D; Ollivierre-Wilson H; Singh A; Krishna MC; Mitchell JB; Rouault TA
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):12028-33. PubMed ID: 18685102
[TBL] [Abstract][Full Text] [Related]
7. Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo.
Meyron-Holtz EG; Ghosh MC; Rouault TA
Science; 2004 Dec; 306(5704):2087-90. PubMed ID: 15604406
[TBL] [Abstract][Full Text] [Related]
8. Regulatory effect of iron regulatory protein-2 on iron metabolism in lung cancer.
Cheng Z; Dai LL; Song YN; Kang Y; Si JM; Xia J; Liu YF
Genet Mol Res; 2014 Jul; 13(3):5514-22. PubMed ID: 25117307
[TBL] [Abstract][Full Text] [Related]
9. Abnormal brain iron metabolism in Irp2 deficient mice is associated with mild neurological and behavioral impairments.
Zumbrennen-Bullough KB; Becker L; Garrett L; Hölter SM; Calzada-Wack J; Mossbrugger I; Quintanilla-Fend L; Racz I; Rathkolb B; Klopstock T; Wurst W; Zimmer A; Wolf E; Fuchs H; Gailus-Durner V; de Angelis MH; Romney SJ; Leibold EA
PLoS One; 2014; 9(6):e98072. PubMed ID: 24896637
[TBL] [Abstract][Full Text] [Related]
10. Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2).
Galy B; Ferring D; Minana B; Bell O; Janser HG; Muckenthaler M; Schümann K; Hentze MW
Blood; 2005 Oct; 106(7):2580-9. PubMed ID: 15956281
[TBL] [Abstract][Full Text] [Related]
11. Role of nitric oxide in cellular iron metabolism.
Kim S; Ponka P
Biometals; 2003 Mar; 16(1):125-35. PubMed ID: 12572672
[TBL] [Abstract][Full Text] [Related]
12. Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2.
Cooperman SS; Meyron-Holtz EG; Olivierre-Wilson H; Ghosh MC; McConnell JP; Rouault TA
Blood; 2005 Aug; 106(3):1084-91. PubMed ID: 15831703
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of iron regulatory protein 2, IRP2, by aluminum.
Yamanaka K; Minato N; Iwai K
FEBS Lett; 1999 Nov; 462(1-2):216-20. PubMed ID: 10580122
[TBL] [Abstract][Full Text] [Related]
14. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis.
Bond CE; McKeone DM; Kalimutho M; Bettington ML; Pearson SA; Dumenil TD; Wockner LF; Burge M; Leggett BA; Whitehall VL
Oncotarget; 2016 Oct; 7(43):70589-70600. PubMed ID: 27661107
[TBL] [Abstract][Full Text] [Related]
15. MAPK inhibitors induce serine peptidase inhibitor Kazal type 1 (SPINK1) secretion in BRAF V600E-mutant colorectal adenocarcinoma.
Räsänen K; Dang KX; Mustonen H; Ho TH; Lintula S; Koistinen H; Stenman UH; Haglund C; Stenman J
Mol Oncol; 2018 Feb; 12(2):224-238. PubMed ID: 29193645
[TBL] [Abstract][Full Text] [Related]
16. Targeting CDK1 and MEK/ERK Overcomes Apoptotic Resistance in BRAF-Mutant Human Colorectal Cancer.
Zhang P; Kawakami H; Liu W; Zeng X; Strebhardt K; Tao K; Huang S; Sinicrope FA
Mol Cancer Res; 2018 Mar; 16(3):378-389. PubMed ID: 29233910
[TBL] [Abstract][Full Text] [Related]
17. Loss of the von Hippel Lindau tumor suppressor disrupts iron homeostasis in renal carcinoma cells.
Alberghini A; Recalcati S; Tacchini L; Santambrogio P; Campanella A; Cairo G
J Biol Chem; 2005 Aug; 280(34):30120-8. PubMed ID: 15985433
[TBL] [Abstract][Full Text] [Related]
18. Iron overload induced by IRP2 gene knockout aggravates symptoms of Parkinson's disease.
Ci YZ; Li H; You LH; Jin Y; Zhou R; Gao G; Hoi MPM; Wang C; Chang YZ; Yu P
Neurochem Int; 2020 Mar; 134():104657. PubMed ID: 31904393
[TBL] [Abstract][Full Text] [Related]
19. [Regulating action of iron regulatory protein-2 in iron metabolism of lung cancer].
Cheng Z; Liu YF; Song YN; Dai LL; Kang Y; Xia J; Si JM; Chen CY
Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(28):1992-5. PubMed ID: 22093897
[TBL] [Abstract][Full Text] [Related]
20. Iron-independent phosphorylation of iron regulatory protein 2 regulates ferritin during the cell cycle.
Wallander ML; Zumbrennen KB; Rodansky ES; Romney SJ; Leibold EA
J Biol Chem; 2008 Aug; 283(35):23589-98. PubMed ID: 18574241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
